Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 26 | 2019 | 152 | 5.450 |
Why?
|
| Tissue Scaffolds | 13 | 2019 | 88 | 2.770 |
Why?
|
| Tendons | 5 | 2017 | 27 | 2.090 |
Why?
|
| Lactic Acid | 7 | 2016 | 89 | 1.770 |
Why?
|
| Bioreactors | 11 | 2019 | 35 | 1.420 |
Why?
|
| Polymers | 7 | 2013 | 114 | 1.390 |
Why?
|
| Osteoblasts | 10 | 2010 | 35 | 1.370 |
Why?
|
| Umbilical Veins | 4 | 2017 | 25 | 1.340 |
Why?
|
| Stress, Mechanical | 9 | 2018 | 104 | 1.320 |
Why?
|
| Bone and Bones | 6 | 2017 | 74 | 1.270 |
Why?
|
| Biocompatible Materials | 5 | 2012 | 90 | 1.220 |
Why?
|
| Extracellular Matrix | 8 | 2017 | 111 | 1.030 |
Why?
|
| Biomimetic Materials | 4 | 2019 | 20 | 1.000 |
Why?
|
| Rats | 20 | 2017 | 1554 | 0.940 |
Why?
|
| Cell Culture Techniques | 9 | 2012 | 115 | 0.920 |
Why?
|
| Oligopeptides | 3 | 2010 | 95 | 0.880 |
Why?
|
| Rats, Wistar | 12 | 2017 | 149 | 0.840 |
Why?
|
| Cell Differentiation | 10 | 2010 | 398 | 0.780 |
Why?
|
| Perfusion | 9 | 2019 | 43 | 0.750 |
Why?
|
| Cell Proliferation | 7 | 2017 | 774 | 0.730 |
Why?
|
| Biosensing Techniques | 2 | 2016 | 41 | 0.710 |
Why?
|
| Glucose | 3 | 2017 | 198 | 0.690 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 17 | 0.650 |
Why?
|
| Cells, Cultured | 12 | 2017 | 976 | 0.640 |
Why?
|
| Animals | 29 | 2017 | 10073 | 0.620 |
Why?
|
| Bone Marrow Cells | 10 | 2013 | 80 | 0.610 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 24 | 0.560 |
Why?
|
| Neoplasms | 3 | 2023 | 765 | 0.540 |
Why?
|
| Metabolome | 1 | 2016 | 66 | 0.510 |
Why?
|
| Polyethylene Glycols | 4 | 2013 | 93 | 0.500 |
Why?
|
| X-Ray Microtomography | 2 | 2012 | 31 | 0.500 |
Why?
|
| Oxygen | 1 | 2016 | 230 | 0.490 |
Why?
|
| Titanium | 7 | 2006 | 34 | 0.470 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2012 | 24 | 0.440 |
Why?
|
| Exosomes | 2 | 2024 | 92 | 0.390 |
Why?
|
| Models, Biological | 3 | 2019 | 448 | 0.370 |
Why?
|
| Surface Properties | 5 | 2019 | 132 | 0.360 |
Why?
|
| Bone Substitutes | 3 | 2005 | 10 | 0.340 |
Why?
|
| Alkaline Phosphatase | 8 | 2010 | 31 | 0.330 |
Why?
|
| Male | 14 | 2017 | 13003 | 0.320 |
Why?
|
| Soft Tissue Injuries | 1 | 2008 | 5 | 0.310 |
Why?
|
| Polyesters | 5 | 2010 | 33 | 0.310 |
Why?
|
| Ligaments | 1 | 2008 | 22 | 0.300 |
Why?
|
| Stromal Cells | 8 | 2013 | 60 | 0.290 |
Why?
|
| Adult Stem Cells | 1 | 2007 | 10 | 0.280 |
Why?
|
| Culture Media | 4 | 2017 | 97 | 0.280 |
Why?
|
| Biomechanical Phenomena | 3 | 2017 | 162 | 0.270 |
Why?
|
| Musculoskeletal System | 1 | 2006 | 6 | 0.260 |
Why?
|
| Humans | 15 | 2024 | 27067 | 0.260 |
Why?
|
| Minerals | 2 | 2019 | 15 | 0.260 |
Why?
|
| Calcification, Physiologic | 1 | 2005 | 4 | 0.240 |
Why?
|
| Tensile Strength | 3 | 2017 | 32 | 0.240 |
Why?
|
| Pyrroles | 1 | 2004 | 35 | 0.230 |
Why?
|
| Implants, Experimental | 1 | 2003 | 3 | 0.230 |
Why?
|
| Calcium | 7 | 2007 | 232 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 626 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 658 | 0.210 |
Why?
|
| Materials Testing | 4 | 2013 | 86 | 0.210 |
Why?
|
| Osseointegration | 1 | 2002 | 3 | 0.210 |
Why?
|
| Regeneration | 2 | 2016 | 76 | 0.200 |
Why?
|
| Bone Development | 1 | 2001 | 6 | 0.190 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 377 | 0.190 |
Why?
|
| Cartilage, Articular | 2 | 2012 | 43 | 0.180 |
Why?
|
| Osteogenesis | 3 | 2012 | 40 | 0.180 |
Why?
|
| Osteocalcin | 3 | 2017 | 9 | 0.170 |
Why?
|
| Tissue Culture Techniques | 2 | 2011 | 31 | 0.170 |
Why?
|
| Prodrugs | 2 | 2017 | 29 | 0.170 |
Why?
|
| Cattle | 3 | 2016 | 383 | 0.160 |
Why?
|
| Porosity | 5 | 2013 | 38 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 566 | 0.150 |
Why?
|
| Osteoprotegerin | 1 | 2017 | 3 | 0.150 |
Why?
|
| Carbon-Sulfur Lyases | 2 | 2017 | 16 | 0.150 |
Why?
|
| Annexin A5 | 2 | 2017 | 24 | 0.140 |
Why?
|
| Diffusion | 2 | 2011 | 37 | 0.140 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 39 | 0.140 |
Why?
|
| Proteins | 1 | 2019 | 245 | 0.140 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 50 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 179 | 0.140 |
Why?
|
| Sirolimus | 1 | 2017 | 69 | 0.130 |
Why?
|
| Collagen Type I | 2 | 2008 | 27 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 144 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2007 | 133 | 0.130 |
Why?
|
| Bone Regeneration | 2 | 2007 | 17 | 0.130 |
Why?
|
| Skull | 2 | 2007 | 36 | 0.130 |
Why?
|
| Rats, Inbred F344 | 2 | 2007 | 168 | 0.120 |
Why?
|
| Friction | 2 | 2012 | 4 | 0.120 |
Why?
|
| Selenomethionine | 1 | 2013 | 5 | 0.110 |
Why?
|
| Shear Strength | 2 | 2012 | 15 | 0.110 |
Why?
|
| Organoselenium Compounds | 1 | 2013 | 8 | 0.110 |
Why?
|
| Methanol | 1 | 2013 | 14 | 0.110 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 21 | 0.110 |
Why?
|
| Ketones | 1 | 2013 | 7 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 27 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2013 | 17 | 0.110 |
Why?
|
| X-Rays | 1 | 2012 | 29 | 0.100 |
Why?
|
| Hydrogels | 2 | 2003 | 52 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2003 | 73 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 42 | 0.090 |
Why?
|
| Permeability | 1 | 2011 | 59 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 85 | 0.090 |
Why?
|
| Microscopy, Polarization | 1 | 2010 | 3 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 246 | 0.090 |
Why?
|
| Rheology | 1 | 2010 | 21 | 0.090 |
Why?
|
| Time Factors | 3 | 2003 | 1570 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 421 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2010 | 129 | 0.080 |
Why?
|
| Umbilical Cord | 1 | 2008 | 35 | 0.080 |
Why?
|
| Mice | 4 | 2017 | 4470 | 0.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2007 | 8 | 0.070 |
Why?
|
| DNA | 3 | 2003 | 365 | 0.070 |
Why?
|
| Elasticity | 1 | 2007 | 49 | 0.070 |
Why?
|
| 3T3 Cells | 1 | 2007 | 44 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2010 | 221 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2006 | 10 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2006 | 26 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 153 | 0.060 |
Why?
|
| Female | 4 | 2024 | 14613 | 0.060 |
Why?
|
| Cartilage | 1 | 2006 | 35 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 1 | 2004 | 19 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 43 | 0.060 |
Why?
|
| Starch | 1 | 2003 | 3 | 0.060 |
Why?
|
| Cell Line | 1 | 2006 | 681 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2003 | 17 | 0.050 |
Why?
|
| Fibronectins | 1 | 2003 | 28 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2003 | 14 | 0.050 |
Why?
|
| Glycolates | 1 | 2002 | 3 | 0.050 |
Why?
|
| Polyglycolic Acid | 1 | 2002 | 36 | 0.050 |
Why?
|
| Solutions | 1 | 2002 | 31 | 0.050 |
Why?
|
| Serum Albumin, Bovine | 1 | 2002 | 22 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2002 | 76 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2023 | 110 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2001 | 11 | 0.050 |
Why?
|
| Antibodies | 1 | 2002 | 124 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2001 | 24 | 0.050 |
Why?
|
| Lubrication | 2 | 2012 | 3 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1267 | 0.050 |
Why?
|
| Phenotype | 1 | 2003 | 666 | 0.050 |
Why?
|
| Kinetics | 1 | 2002 | 538 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 546 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 216 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 100 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 108 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 251 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 229 | 0.030 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 8 | 0.030 |
Why?
|
| Osteopontin | 2 | 2006 | 10 | 0.030 |
Why?
|
| Enzyme Therapy | 1 | 2013 | 2 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 59 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 88 | 0.030 |
Why?
|
| Benzophenones | 1 | 2013 | 3 | 0.030 |
Why?
|
| Viscoelastic Substances | 1 | 2013 | 2 | 0.030 |
Why?
|
| Quartz Crystal Microbalance Techniques | 1 | 2012 | 2 | 0.020 |
Why?
|
| Lubricants | 1 | 2012 | 3 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2012 | 12 | 0.020 |
Why?
|
| Viscosity | 1 | 2012 | 37 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1405 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 90 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2013 | 145 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2012 | 95 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2010 | 65 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 447 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2003 | 14 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 110 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2003 | 6 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 168 | 0.010 |
Why?
|
| Bone Matrix | 1 | 2002 | 4 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 109 | 0.010 |
Why?
|
| Freezing | 1 | 2002 | 21 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 589 | 0.010 |
Why?
|